Munich - Delayed Quote • EUR
Mithra Pharmaceuticals SA (1TM.MU)
At close: April 26 at 8:11 AM GMT+2
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
62,675.0000
66,997.0000
22,668.0000
9,030.0000
Cost of Revenue
20,970.0000
19,623.0000
15,724.0000
3,457.0000
Gross Profit
41,705.0000
47,374.0000
6,944.0000
5,573.0000
Operating Expense
80,631.0000
73,620.0000
94,820.0000
89,251.0000
Operating Income
-38,926.0000
-26,246.0000
-87,876.0000
-83,678.0000
Net Non Operating Interest Income Expense
-17,872.0000
-13,349.0000
-10,304.0000
-4,746.0000
Pretax Income
-33,963.0000
-11,480.0000
-123,769.0000
-110,922.0000
Tax Provision
44,878.0000
48,139.0000
-6,895.0000
-18,835.0000
Net Income Common Stockholders
-78,842.0000
-59,620.0000
-116,875.0000
-92,086.0000
Diluted NI Available to Com Stockholders
-78,842.0000
-59,620.0000
-116,875.0000
-92,086.0000
Basic EPS
-1.41
-1.22
-2.69
-2.25
Diluted EPS
-1.41
-1.22
-2.69
-2.25
Basic Average Shares
55,086.5000
49,059.4580
43,429.8090
40,988.2350
Diluted Average Shares
55,086.5000
49,059.4580
43,429.8090
40,988.2350
Total Operating Income as Reported
-38,927.0000
-26,245.0000
-87,875.0000
-83,678.0000
Rent Expense Supplemental
86.0000
--
--
83.0000
Total Expenses
101,601.0000
93,243.0000
110,544.0000
92,708.0000
Net Income from Continuing & Discontinued Operation
-78,842.0000
-59,620.0000
-116,875.0000
-92,086.0000
Normalized Income
-76,748.7500
-61,483.7500
-111,224.3604
-87,997.2847
Interest Income
2,534.0000
3,682.0000
2,121.0000
--
Interest Expense
20,377.0000
17,002.0000
11,765.0000
3,503.0000
Net Interest Income
-17,872.0000
-13,349.0000
-10,304.0000
-4,746.0000
EBIT
-13,586.0000
5,522.0000
-112,004.0000
-107,419.0000
EBITDA
-1,320.0000
17,462.0000
-101,578.0000
-97,652.0000
Reconciled Cost of Revenue
20,970.0000
19,623.0000
15,724.0000
3,457.0000
Reconciled Depreciation
12,266.0000
11,940.0000
10,426.0000
9,767.0000
Net Income from Continuing Operation Net Minority Interest
-78,842.0000
-59,620.0000
-116,875.0000
-92,086.0000
Total Unusual Items Excluding Goodwill
-2,791.0000
2,485.0000
-5,984.0000
-4,925.0000
Total Unusual Items
-2,791.0000
2,485.0000
-5,984.0000
-4,925.0000
Normalized EBITDA
1,471.0000
14,977.0000
-95,594.0000
-92,727.0000
Tax Rate for Calcs
0.0003
0.0003
0.0001
0.0002
Tax Effect of Unusual Items
-697.7500
621.2500
-333.3604
-836.2847
12/31/2020 - 2/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade